文献速递生殖医学

人绒毛膜促性腺激素触发后与黄体生成素峰值后行宫腔内人工授精:一项荟萃分析

Intrauterine Insemination After Human Chorionic Gonadotropin Trigger or Luteinizing Hormone Surge: A Meta-analysis.
PubMed 文献 · Obstet Gynecol · 2023-06-07

本荟萃分析比较超声监测后给予人绒毛膜促性腺激素(hCG)触发与监测黄体生成素(LH)峰值两种时机行宫腔内人工授精(IUI)的妊娠结局。共纳入13项研究,结果显示两组妊娠几率无显著差异(OR 0.92,95%CI 0.69-1.22,P=.53),自然周期及口服药物刺激周期亚组亦无显著差异,但研究间存在统计学显著异质性。

要点

  • hCG触发与LH峰值监测两种时机行IUI的妊娠几率无显著差异(OR 0.92,95%CI 0.69-1.22,P=.53)。
  • 自然周期亚组(5项研究)两组妊娠几率无显著差异(OR 0.88,95%CI 0.46-1.69,P=.61)。
  • 口服药物刺激周期亚组(10项研究)两组妊娠几率无显著差异(OR 0.88,95%CI 0.66-1.16,P=.32)。

核心结论

  • 本荟萃分析显示,在家监测LH与定时IUI之间的妊娠结局无差异。

研究设计与样本

  • 检索PubMed(MEDLINE)、EMBASE(Elsevier)、Scopus(Elsevier)、Web of Science(Clarivate Analytics)、ClinicalTrials.gov(National Institutes of Health)和Cochrane Library(Wiley),从建库至2022年10月1日,无语言限制。
  • 去重后对3,607条独特文献由三名研究者进行盲法独立审查。
  • 最终纳入13项研究(5项回顾性队列、4项横断面、2项随机对照试验、2项随机交叉研究),纳入接受自然周期、口服药物(克罗米芬或来曲唑)或两者兼有的IUI女性,采用随机效应模型进行荟萃分析。
  • 采用Downs and Black清单评估纳入研究的方法学质量。

主要发现

  • hCG给药与内源性LH监测两组妊娠几率无显著差异(OR 0.92,95%CI 0.69-1.22,P=.53)。
  • 纳入自然周期IUI结局的5项研究亚组分析显示,两种方法妊娠几率无显著差异(OR 0.88,95%CI 0.46-1.69,P=.61)。
  • 纳入口服药物(克罗米芬或来曲唑)卵巢刺激女性的10项研究亚组分析显示,超声联合hCG触发与LH定时IUI两组妊娠几率无差异(OR 0.88,95%CI 0.66-1.16,P=.32)。
  • 研究间存在统计学显著异质性。

关键数值与推荐

  • 主要结局为妊娠几率,hCG给药组与LH监测组比较OR 0.92(95%CI 0.69-1.22,P=.53)。
  • 自然周期亚组OR 0.88(95%CI 0.46-1.69,P=.61)。
  • 口服药物刺激周期亚组OR 0.88(95%CI 0.66-1.16,P=.32)。

局限性

  • 研究间存在统计学显著异质性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To assess the odds of pregnancy after intrauterine insemination (IUI) timed by ultrasound monitoring and human chorionic gonadotropin (hCG) administration compared with monitoring luteinizing hormone (LH) levels. DATA SOURCES: We searched PubMed (MEDLINE), EMBASE (Elsevier), Scopus (Elsevier), Web of Science (Clarivate Analytics), ClinicalTrials.gov (National Institutes of Health), and the Cochrane Library (Wiley) from the inception until October 1, 2022. No language limitations were applied. METHODS OF STUDY SELECTION: After deduplication, 3,607 unique citations were subjected to blinded independent review by three investigators. Thirteen studies (five retrospective cohort, four cross-sectional, two randomized controlled trials, and two randomized crossover studies) that enrolled women undergoing natural cycle, oral medication (clomid or letrozole), or both for IUI were included in the final random-effects model meta-analysis. Methodologic quality of included studies was assessed with the Downs and Black checklist. TABULATION, INTEGRATION, AND RESULTS: Data extraction was compiled by two authors, including publication information, hCG and LH monitoring guidelines, and pregnancy outcomes. No significant difference in odds of pregnancy between hCG administration and endogenous LH monitoring was observed (odds ratio [OR] 0.92, 95% CI 0.69-1.22, P =.53). Subgroup analysis of the five studies that included natural cycle IUI outcomes also showed no significant difference in odds of pregnancy between the two methods (OR 0.88, 95% CI 0.46-1.69, P =.61). Finally, a subgroup analysis of 10 studies that included women who underwent ovarian stimulation with oral medications (clomid or letrozole) did not demonstrate a difference in odds of pregnancy between ultrasonography with hCG trigger and LH-timed IUI (OR 0.88, 95% CI 0.66-1.16, P =.32). Statistically significant heterogeneity was noted between studies. CONCLUSION: This meta-analysis showed no difference between pregnancy outcomes between at-home LH monitoring and timed IUI. SYSTEMATIC REVIEW REGISTRATION: PROSPERO, CRD42021230520.

来源:Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Potapragada NR, Babayev E, Strom D, et al. Intrauterine Insemination After Human Chorionic Gonadotropin Trigger or Luteinizing Hormone Surge: A Meta-analysis. Obstet Gynecol. 2023. PMID: 37290111. doi:10.1097/AOG.0000000000005222

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。